PHOENIX, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (CELZ) (“Creative Medical”), a clinical-stage biotechnology company advancing regenerative medicine solutions, ...

Silicon Prairie Startup Week attendees get a firsthand experience playing the OVRP’s virtual reality game at Catalyst on October 9. Each player learns how to intubate a patient in the virtual hospital ...

“We were pleased to present the significant progress we have made with our Proteus development program and provide the data behind why we believe this will be a market changing product in the field of ...

Quantum-Si to Highlight Significant Proteus™ Platform Development Progress and Provide Insights into the Company’s Industry Leading Technology Pipeline at Investor & Analyst Day Quantum-Si ...

Biotechnology company Eikon Therapeutics announced the initial closing of a $350.7 million Series D financing round that it will use to advance its clinical-stage programs. The new funding brings the ...

The joint guidance was created to ensure drug developers employ best practices when using AI.

Novavax’s president and CEO reviewed the company’s successes in 2025 and shared its growth strategy for 2026 and beyond at a ...

Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic potential Synergistic and complementary to Lee's Pharm's existing products pipeline, and ...

MARTINSRIED, Germany--(BUSINESS WIRE)--SIRION Biotech GmbH announced today that Beam Therapeutics licensed rights to use SIRION Biotech’s LentiBOOST™ for use in their CAR-T cell products. CAR-T cell ...